Clorox (NYSE:CLX) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Clorox (NYSE:CLX) had its price objective upped by research analysts at JPMorgan Chase & Co. from $114.00 to $117.00 in a note issued to investors on Wednesday, MarketBeat reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential downside of 0.51% from the company’s previous close.

Other equities research analysts have also recently issued research reports about the stock. TD Cowen reaffirmed a “hold” rating on shares of Clorox in a research note on Thursday, January 8th. BNP Paribas Exane dropped their price target on shares of Clorox from $103.00 to $101.00 and set an “underperform” rating on the stock in a research report on Friday, January 16th. Jefferies Financial Group decreased their price objective on shares of Clorox from $152.00 to $151.00 and set a “buy” rating for the company in a research report on Wednesday. Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Finally, Citigroup upped their price target on Clorox from $109.00 to $115.00 and gave the stock a “neutral” rating in a report on Wednesday. One equities research analyst has rated the stock with a Buy rating, ten have given a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average price target of $117.93.

Clorox Price Performance

Shares of CLX opened at $117.59 on Wednesday. The business’s 50-day moving average is $105.58 and its two-hundred day moving average is $114.01. The company has a market capitalization of $14.22 billion, a P/E ratio of 19.21, a P/E/G ratio of 0.57 and a beta of 0.59. Clorox has a fifty-two week low of $96.66 and a fifty-two week high of $159.04. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.50 and a current ratio of 0.74.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The business’s quarterly revenue was down .8% compared to the same quarter last year. During the same period last year, the firm earned $1.55 EPS. Research analysts predict that Clorox will post 7.15 earnings per share for the current year.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of Clorox stock in a transaction on Friday, November 21st. The stock was acquired at an average price of $104.13 per share, with a total value of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is owned by insiders.

Institutional Trading of Clorox

Several large investors have recently made changes to their positions in CLX. Total Investment Management Inc. acquired a new stake in Clorox during the second quarter worth about $25,000. Center for Financial Planning Inc. purchased a new stake in shares of Clorox in the 3rd quarter valued at approximately $25,000. Vermillion & White Wealth Management Group LLC purchased a new stake in shares of Clorox in the 3rd quarter valued at approximately $25,000. NewSquare Capital LLC increased its holdings in shares of Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after buying an additional 193 shares during the last quarter. Finally, True Wealth Design LLC raised its position in shares of Clorox by 1,020.0% during the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after buying an additional 204 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target to $136 (equal-weight), signaling meaningful upside versus the current level and providing buy-side support. Article Title
• Positive Sentiment: Jefferies kept a Buy rating and a high target (~$151), reinforcing a bullish view on longer-term recovery and giving investors a favorable risk/reward case. Article Title
• Neutral Sentiment: Clorox reiterated its 2026 outlook despite mixed Q2 results, which limits downside if management delivers on guidance and execution. Article Title
• Neutral Sentiment: Clorox will present at the CAGNY conference (Feb. 19), offering investors a near-term opportunity for management to outline strategy and provide more color on ERP integration and potential M&A (GOJO). Article Title
• Negative Sentiment: Q2 results were mixed: adjusted EPS missed estimates ($1.39 vs. $1.43), organic sales fell year-over-year, and margin pressure from higher costs and ERP-related expenses was highlighted — primary near-term negative catalyst. Article Title
• Negative Sentiment: Evercore cut its target sharply to $115 and kept an Underperform rating, increasing sell-side pressure and signalling concerns about near-term profitability. Article Title
• Negative Sentiment: Deutsche Bank trimmed its target to $112 (hold), and TD Cowen’s $111 target (hold) also implies downside — several shops are skeptical on margins and the ERP/integration timeline. Article Title Article Title
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 miss even while nudging its target to $112 — a reminder margins and execution (inventory reset, ERP) are the biggest risks near term. Article Title

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.